BiotechTube
Home/Pipeline/Exo‑Autism

Exo‑Autism

Autism Spectrum Disorder

Phase 1Active

Key Facts

Indication
Autism Spectrum Disorder
Phase
Phase 1
Status
Active
Company
Advancells

About Advancells

India’s leading GMP‑compliant stem‑cell and exosome therapy provider for personalized regenerative medicine.

View full company profile

Therapeutic Areas

Regenerative MedicineNeurologyOrthopedicsDermatologyReproductive HealthOphthalmology

Other Autism Spectrum Disorder Drugs

DrugCompanyPhase
NTI164Neurotech InternationalPhase 3
Autism ProgramIgnite BiomedicalDiscovery
Kingdom Therapeutics CollaborationCeladon PharmaceuticalsPre-clinical
MDXX‑2PharmAla BiotechPreclinical
NeuroNOS-1NeuroNOSPreclinical
Banked Cord Blood Stem CellsCryo-CellClinical Trials